Dasatinib Sandoz 140 mg, Filmtabletten - 30 Swissmedic Key 67368006 Registration Holder Sandoz Pharmaceuticals AG Name Dasatinib Sandoz 140 mg, Filmtabletten Date of registration 08.10.2020 Introduction of Sequence 08.10.2020 ATC-Classification Dasatinib (L01EA02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 30 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680673680063 Medication Code Synthetika Pharmacode Disponibility
Composition dasatinibum 140 mg, cellulosum microcristallinum, lactosum monohydricum 193.2 mg, carmellosum natricum conexum, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, glyceroli monopalmitostearas, natrii laurilsulfas, pro compresso obducto corresp. natrium 4.077 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dasatinib 140 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Glyceroli Monopalmitostearas Hydroxypropylcellulosum Lactose Monohydrate 193.2 mg Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
